# Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

> **NCT00721513** · PHASE2 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 20 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **BIOLOGICAL:** cetuximab
- **DRUG:** cisplatin
- **DRUG:** docetaxel
- **DRUG:** fluorouracil
- **PROCEDURE:** computed tomography
- **PROCEDURE:** positron emission tomography
- **PROCEDURE:** quality-of-life assessment
- **RADIATION:** 3-dimensional conformal radiation therapy
- **RADIATION:** intensity-modulated radiation therapy

## Key facts

- **NCT ID:** NCT00721513
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00721513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00721513, "Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00721513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*